Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with my...
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
About this item
Full title
Author / Creator
Mele, G. , Cascavilla, N. , Di Renzo, N. , Guarini, A. , Mazza, P. , Melillo, L. , Pavone, V. , Tarantini, G. , Curci, P. , Falcone, A. P. , Germano, C. , Mele, A. , Palazzo, G. , Palumbo, G. , Reddiconto, G. , Rossini, B. , Specchia, G. , Musto, P. and Pastore, D.
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
We report herein a multicentre retrospective analysis of 192 consecutive patients with symptomatic refractory/relapsed multiple myeloma (RRMM) treated with daratumumab in combination with bortezomib or lenalidomide as salvage therapy at 9 haematological centres in Puglia. Choice of both regimens was based on previous treatment and/or physicians’ pr...
Alternative Titles
Full title
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2667785106
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2667785106
Other Identifiers
ISSN
0939-5555
E-ISSN
1432-0584
DOI
10.1007/s00277-022-04857-0
